Strong domestic offset by export collapse, prior guidance missed
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 5/10
Grade C
Prior FY27 double-digit revenue growth guidance; Q1 delivered 6.8%. MD walked it back to industry 6-8% mid-call. Seeds 'high double-digit' guidance now 'mid-to-high single digits minus cotton'.
Neutral
next 1–2 quarters
Optimistic
multi-year
Q1 beat on EPS (+31.6% PAT) but missed prior revenue guidance (6.8% vs implied 10%+). Domestic crop care resilience (+19% B2C) offset by cotton sector collapse (-25-35% acreage), weak exports (-28%), and monsoon-dependent recovery path. Working capital stress (+15-20 days) from fertilizer hoarding. Key risk: kharif volume recovery contingent on below-normal rainfall (<90% LPA) and farmer cash availability.
₹1022 Cr
Revenue · +6.8% YoY₹125 Cr
Reported PAT · +31.6% YoYExpanding
Margins · vs guidance: OverstatedDid the claims hold up?
Reasonable Q1FY27 performance despite headwinds
OVERSTATEDRevenue +6.8% YoY misses prior FY27 double-digit guidance; growth from pre-placement and mix-shift
Domestic crop care driving growth with volume momentum
PartialDomestic B2C +19% but driven by aggressive pre-placement and liquidation efforts, not organic demand
Price increases reflected in results
OVERSTATEDOnly 5% price growth; market did not accept increases until May-end/June; selective pass-through
Seeds business poised for high double-digit growth
MISSSeeds +6% YoY, all price-driven; volume under pressure from cotton acreage collapse (-25-35%)
CSM showing promising growth trajectory
METCSM +191% but from tiny base (₹8 to ₹24 Cr); MD admits 'slow burn' requiring years to scale
Export business competitive
MISSExports -28% due to Chinese pricing pressure on acephate, weak Europe/Brazil demand
Earnings quality
What changed since the last call
FY27 growth guidance downgrade
DowngradePrior call: 'double-digit revenue growth' for FY27. Q1 call: 'industry expected to grow 6-8%' (agrochemicals), implying full-year is lower than guided
Seeds growth forecast cut
DowngradePrior: 'high double-digit growth in seeds business'. Now: 'mid-to-high single digits minus cotton' due to cotton acreage collapse and shift to rice/maize
Cotton sector outlook deteriorated
DowngradeNorth cotton acreage -25%, South/Central -35%, illegal HTBT spread; MD now guides 'flat cotton year' vs prior expectation of growth
Export trajectory reset
DowngradeQ1 exports -28%; MD acknowledges Chinese competition on catalogues is structural. CSM ramp ('slow burn') will take years vs near-term boost assumed
Margin sustainability reaffirmed
NeutralPrior guidance 'stable-to-soft' margins; delivered 18.3% OPM and 18% EBITDA margin (184 Cr / 1022 Cr) = aligned. No surprise.
Pricing power limited mid-season
DowngradeMD: price increases 'generally very difficult' mid-season; selective pass-through; will depend on competitive intensity. Implies margin pressure if volumes soft
The Q&A
Analysts pressed hard on guidance misses and execution risk. MD was defensive on exports (product-specific challenges, slow CSM ramp) but transparent on monsoon/volume uncertainty; repeatedly said 'too early to predict until August.' Candid on cotton headwinds but optimistic on long-term margin/R&D trajectory. No evasion detected but limited forward visibility offered.
Export competitiveness — Ankur Periwal, Axis Capital
AnsweredCSM is okay due to contracts. Catalogues under pressure, especially acephate (raw material from China). Other products (Pendy, metribuzin, hexaconazole) still competitive. CSM ramp slow but progressing; 3-4 products in pipeline over 3 years.
Cotton sector outlook — Ankur Periwal, Axis Capital
AnsweredCotton likely flat year; pivoting focus to rice, maize, millet. North cotton down 25%, illegal HTBT spread in South. But markets sometimes rain even with lower acreage if farmers can spray; too early to predict September-October rain.
El Niño and monsoon impact — Praneet, SJ Investments
PartialRainfall 15% below normal; but 50% of area irrigated. Delayed sowing but catch-up happening. Farmers shifting to pulses/oilseeds but cotton/groundnut down. Crop shift varies by region. 90-95% of acreage likely planted even in worst case.
Volume vs. pricing growth — Praneet, SJ Investments
DodgedVery difficult to predict. Depending on rainfall distribution, lower acreage with good spray windows may offset via higher spray intensity. Too early to call until mid-August.
Pricing pass-through — Praneet, SJ Investments
AnsweredSelective pass-through; some full, some partial, some none. Price increases hard mid-season. Market acceptance only in June after March cost uptick. Focus now on volume/market share, not further price hikes.
Channel inventory normalization — Praneet, SJ Investments
AnsweredNormalized now; was worse a month ago. Product mix shifting (pre-emergent to post-emergent herbicides in soybean). Being cautious on return provisioning; accounting more rather than less given uncertainty.
Long-term competitive advantage — Sonika Padulia, Millennium Mams
AnsweredBrand strength. Portfolio R&D focus (narrowed to 5 seed crops, stopped GM/vegetable seeds). Enhanced digital/customer outreach. Soil & plant health organic capability build. Target: 500 bps EBITDA margin expansion over 5 years; on track.
R&D project evaluation — Sonika Padulia, Millennium Mams
AnsweredFocused on 5 strategic seed crops only; stopped vegetable/GM crops. Portfolio dept strengthened; added product dev layer between marketing/R&D/sales for rigor. B2B team for global collaborations.
Rupee depreciation impact on B2B — Rajakumar Vaidyanathan, RK Investments
AnsweredDouble-edged (buy raw material in dollars). But net exporter; net-net positive. Despite lower export volume, profitability contribution grown. Competitive pressure from Chinese remains product-specific.
Chilli crop recovery — Rajakumar Vaidyanathan, RK Investments
AnsweredChilli important contributor; product-specific (Cluster) suffered last year due to low commodity prices. This year chilli planting positive with high prices; recovery expected in Q2-Q3. Sugarcane broadly positive if water available.
Cotton shift to short-duration crops — Rohit Nagraj, 360 ONE Capital
PartialDepends. Lower acreage with open spray window may offset via higher intensity. Farmers will protect if commodity prices firm up. Situational; too early to predict.
Biologicals segment traction — Rohit Nagraj, 360 ONE Capital
AnsweredSmaller segment but more profitable. Q1 grew 10% despite slow sowing. Expect faster pickup as sowing accelerates; positive regulatory environment; no portfolio constraints.
Seed production scarcity risk — Rohit Nagraj, 360 ONE Capital
AnsweredUnpredictable. Companies carry forward 30-50% next-year cotton seed inventory (no challenge). Other crops planted October-April. Seed industry has excess this year; should help next season.
Employee cost spike — Abhijit Akella, Kotak Securities
Answered₹35 Cr reversal: ₹10-11 Cr recurring (Q1 performance incentive settlement), ₹24 Cr non-recurring (restructuring/retiral). Underlying cost increase ~12% (normal inflation). Non-recurring won't repeat.
FY27 industry growth guidance — Abhijit Akella, Kotak Securities
AnsweredFair to assume pricing power will offset volume drag. Market balanced; no panic. Price increase alone should deliver 6-8%. Unless oversupply/discounting panic emerge.
Working capital deterioration — Himani Badetia, ICICI Prudential
AnsweredFertilizer shortage panic-buying blocked farmer cash; rationing of other inputs. Industry-wide. Collection cycles smooth but cash conversion longer.
Sales returns provisioning — Himani Badetia, ICICI Prudential
AnsweredCotton seed North India taken back in Q1 itself. Crop/product-specific. Pre-emergence herbicides for rice, soybean, groundnut taken back in kharif. Normal practice; no point leaving unsold inventory.
Capacity utilization and capex returns — Himani Badetia, ICICI Prudential
DodgedPlant-specific; will ask Chirjeev to follow up with details.
Direct seeded rice opportunity — Riju, Antique Stock Broking
AnsweredDirect seeded rice increases pre/post-emergence consumption. We launched new rice herbicide and in-licensing direct seeded rice tech. Pilot sales in Chhattisgarh; participating in segment.
Herbicide business trajectory — Riju, Antique Stock Broking
Answered2 years ago we said herbicide was weakness. Now Q1 herbicide is largest category contributor (+12%); largest followed by insecticide/fungicide. Actively adding products.
Inventory prebuy profitability — Riju, Antique Stock Broking
PartialYes, procured for kharif due to war uncertainty and daily price spikes. Can't quantify until season end (different costs mixed). Had cash to negotiate better discounts. Should have positive impact overall.
Price hike acceptance and pass-through — Riju, Antique Stock Broking
PartialPrice increases not accepted until May-end/June; earlier in quarter there was zero market realization. June saw liquidation of March-stocked material at new prices. Combination of volume and price is helping us.
Generic product imports and inventory — Riju, Antique Stock Broking
AnsweredNormal levels. Initially looked inactive but delayed monsoon gave them extra time. Not sitting on high inventory industry-wide; normal levels.
Maize price weakness and crop shifting — Riju, Antique Stock Broking
AnsweredRegional constraints (Vidarbha: either cotton or soybean). Shift also commodity/rainfall driven. If more soybean: more herbicide, less insecticide. If cotton: less herbicide, more insecticide/fungicide. Farmers' logic varies by crop.
Guidance
FY27 agrochemical industry growth 6-8% (vs prior 'double-digit')
MediumPricing power expected to deliver 6-8% growth despite lower acreage; assumes no panic discounting; market balanced
Seeds growth mid-to-high single digits (excluding cotton)
MediumCotton flat/slightly negative; rice, maize, millet driving growth; subject to kharif rainfall and farmer cash recovery
CSM contribution slow ramp; 3-4 products over next 3 years
LowOnly ₹24 Cr this quarter from ₹8 Cr; MD admits 'slow burn' requiring sustained cultivation; no near-term material impact expected
Margins stable-to-soft; EBITDA ~18% sustainable
MediumQ1 delivered 18% EBITDA (184 Cr / 1022 Cr); mix shift and pricing offsetting cost inflation; but working capital drag and volume uncertainty remain
5-year target: 500 bps EBITDA margin improvement (currently ~18%, target ~23%)
Medium100 bps per year improvement via R&D, portfolio premiumization, seed/soil & plant health expansion; long-term, not near-term
Formulation capacity utilization increased Q1 vs prior year
LowNo specific capex numbers provided; MD deferred to Chirjeev for plant-by-plant detail; incremental sales from prior capex unclear
Risks the call surfaced
Monsoon / Kharif timing
HighRainfall 15% below normal as of July 8; IMD forecast ~90% LPA with model error ±4%; regional deficits in east/northeast/south; sowing lagging -23% YoY; volume recovery highly uncertain
Cotton acreage collapse
HighNorth India cotton -25% acreage; South/Central -35%; illegal HTBT cotton spread; company historically heavy on cotton both seeds and crop protection; expected flat/negative cotton year vs prior growth assumption
Export competitiveness (Chinese pricing)
HighExports -28% YoY; Chinese APIs undercutting on acephate, pendy, hexaconazole in Brazil/US/Europe; CSM ramp slow (described as 'slow burn'); contract manufacturing only bright spot but at scale of ₹24 Cr vs ₹110 Cr export base
Working capital deterioration
MediumWorking capital +15-20 days vs prior year due to fertilizer shortage panic-buying blocking farmer cash; inventory still elevated vs prior year; return provisions uncertain given crop volatility; cash conversion cycle elongated
Guidance miss credibility
MediumPrior FY27 guidance was 'double-digit revenue growth'; Q1 delivered 6.8% YoY, forcing downgrade to 'industry 6-8%' mid-call. Seeds downgraded from 'high double-digit' to 'mid-to-high single digits minus cotton'. Risk that further misses emerge if monsoon/kharif underperforms
Management
Score 6/10. Transparent on headwinds and uncertainty; repeatedly deferred volume forecasts to 'August clarity' rather than over-guiding. Candid on competitive pressures (Chinese, unorganized consolidation). Defensive on exports but honest about 'slow burn' CSM ramp. However, guidance downgrade mid-call (6.8% delivery vs prior 'double-digit' expectation) raises credibility questions. Mixed track record. Q1 beat on PAT (+31.6%) but missed on revenue (+6.8% vs implied 10%+). Growth driven by pre-placement/liquidation, not organic demand. Export volumes -28%. Domestic growth artificial. Seed volumes under pressure. Margin stability achieved via mix shift away from weak cotton, not organic efficiency. Long-term initiatives (R&D, digital, portfolio) show rigor but near-term execution challenged.
1 · Aug–Sep 2026
Kharif sowing completion and rainfall normalcy; volume offtake visibility for Q2
2 · Q2 FY27
Chilli and sugarcane crop recovery; MD expects Q2-Q3 traction on commodity price strength
3 · Sep 2026
Rabi procurement cycle; raw material cost direction as fresh buying resumes post-kharif stocking
Key risk: kharif volume recovery contingent on below-normal rainfall (<90% LPA) and farmer cash availability.
Reported Profit Masks Revenue Miss; Market Reaction Justified
PAT jumped 31.6% but revenue limped at 6.8% YoY, missing prior 'double-digit' FY27 guidance. The gap widens when you strip ₹35 Cr in one-time reversals and recognize that 'domestic growth' was driven by aggressive pre-placement, not organic demand recovery.
₹125 Cr
+31.6% YoY
₹35 Cr
₹24 Cr restructuring + ₹11 Cr incentive
~₹90 Cr
+15–20% organic
₹1022 Cr, +6.8%
Misses prior 'double-digit' FY27 target
The market's 7.46% three-day sell-off was justified. While PAT landed +31.6%, the quarter masked a revenue miss and revealed that the company's own guidance for FY27 was overcooked. Prior management commentary promised 'double-digit revenue growth' for the full year; Q1 delivered 6.8%, forcing a reset mid-call to 'industry 6–8% agrochemical growth.' Revenue growth was also not organic — it was driven by aggressive pre-placement (channel fill ahead of uncertain demand) and liquidation of March-stocked material, not recovery in underlying crop protection or seed demand.
The PAT reconciliation: where the beat came from
Reported PAT of ₹125 Cr benefited from ₹24 Cr non-recurring provision reversal (restructuring/retiral) plus ₹11 Cr Q1-specific performance incentive settlement — a combined ₹35 Cr one-time tailwind. Strip these, and adjusted PAT lands around ₹90 Cr, a far more modest +15–20% organic growth rate. The beat was real on EBITDA (+23% to ₹184 Cr), but the margin expansion was driven by product mix shift away from weak cotton seeds toward higher-margin rice and maize, not by organic operational leverage or pricing power.
Management's claims vs. reality
Domestic crop care driving growth with volume momentum
Domestic B2C +19% (₹534 Cr) but MD explicitly said 'aggressive preplacement, liquidation efforts, volume scale up' — not organic recovery
Overstated
Seeds business poised for high double-digit growth
Seeds +6% YoY (₹325 Cr); 100% price-driven, zero volume growth; cotton acreage -25–35% drives shift to rice/maize
Contradicted
Price increases reflected in results
Only 5% price realization; market rejection until May-end/June; selective pass-through vs. raw material inflation
Overstated
Export business competitive
Exports -28% YoY; Chinese competition on acephate, weak Brazil/Europe demand; CSM +191% but tiny base (₹24 Cr), MD admits 'slow burn' over years
Contradicted
Margins stable-to-soft
OPM 18.3%, EBITDA margin 18%; aligned with prior guidance; but expansion from mix-shift, not organic efficiency
Supported (but mix-driven)
What changed from prior guidance
FY27 revenue growth: 'double-digit' → industry 6–8%
Seeds growth: 'high double-digit' → mid-to-high single digits (minus cotton)
Cotton outlook: growth expected → flat/negative year
Export trajectory: CSM ramp reset as 'slow burn', 3–4 years to scale
Pricing power: limited mid-season; selective pass-through only
How the street is positioned
The market's verdict was swift. The stock dropped 4.69% on day-1 (announcement July 20, from pre-result close ₹239.87) and faded further to -7.46% by day-3. Three weeks later, it sits at ₹221.59, down 28.53% from its all-time high of ₹310.05, and below all major moving averages (SMA20 ₹228.39, SMA50 ₹233.75, SMA200 ₹255.59). RSI sits at 41.9, suggesting neutral momentum — not oversold, but not in recovery mode either.
Institutional positioning has turned cautious. FII ownership dipped 53 basis points quarter-on-quarter (from 12.08% to 11.55%), while DII stayed flat (+2 basis points). FII has been trimming since Q2 FY-2026, when they held 14.20%. The sell-off and relative underperformance are consistent with the fundamental case: guidance miss, artificial growth mechanics, and monsoon-dependent recovery path. Promoter ownership remains locked at 55.08%, so capital allocation risk is low; the concern is operational execution against a tougher external backdrop.
Monsoon failure and kharif sowing lag
HighRainfall 15% below normal as of July 8; IMD forecast ~90% LPA; kharif sowing lagged -23% YoY as of late June. If August–September rain is below-normal and patchy, volume offtake will miss again, forcing further guidance cuts.
Cotton acreage collapse (–25–35%)
HighCompany portfolio historically heavy on cotton seeds and crop protection. North India down 25%, South/Central down 35%. Shift to rice/maize/millet is necessary but takes time; near-term volume headwind and mix drag until stable.
Export competitiveness under Chinese pressure
HighExports -28% YoY; acephate raw material sourced from China, creating a structural cost disadvantage vs. direct Chinese competitors. CSM ramp is high-margin but tiny (₹24 Cr) and slow ('slow burn', 3–4 years). Near-term export recovery unlikely; may remain a drag.
Pre-placement sales pulling forward demand
Medium-HighDomestic B2C +19% was driven by 'aggressive preplacement, liquidation efforts'. If farmers and channels do not absorb this inventory, Q2 will see elevated returns and demand cancellations. MD provisioning 'more rather than less' — a telltale of risk awareness.
Working capital deterioration
MediumInventory and receivables up +15–20 days vs. prior year due to fertilizer shortage panic-buying. Cash conversion cycle elongated. Company has ₹309 Cr liquidity buffer, but cash deployment is constrained. Risk escalates if monsoon misses and volumes collapse.
Guidance credibility erosion
MediumPrior FY27 guidance promised 'double-digit revenue growth'. Q1 delivered 6.8%, forcing mid-call reset to 'industry 6–8%'. If monsoon or kharif disappoints again, credibility gap widens and multiple compression accelerates.
1 · Kharif sowing and rainfall tracking
By end of August, track cumulative monsoon rainfall vs. IMD forecast and sowing progress (currently -23% lag). Recovery visibility here determines Q2 volume trajectory and whether management can defend mid-single-digit FY27 growth.
2 · Q2 organic growth ex pre-placement
Pre-placement is a Q1 phenomenon. Watch whether Q2 revenue resets to low single-digit organic growth or shows sign of demand stabilization. Returns/cancellations on Q1 preplacement will be the tell.
3 · Export volume trend and CSM pipeline
Track export revenue trajectory (currently -28%). Confirm whether CSM ramp is on track for 3–4 product launches and whether new customers beyond the first US customer are in pipeline. CSM margin is high (30%+) but scale is critical.
4 · Working capital normalization
Monitor inventory and receivable days as kharif progresses. If farmer cash recovers and channel inventory normalizes, WC should compress back to historical levels by Q3. Failure to normalize would signal deeper demand stress.
5 · Chilli and sugarcane crop recovery
Management highlighted Q2–Q3 traction expected on chilli (high commodity prices driving planting) and sugarcane (if water availability cooperates). These crops are high-margin contributors. Real growth here offsets cotton decline.
RALLIS delivered a reported PAT beat but revenue miss in a quarter defined by monsoon delay, farmer cash crunch, and cotton sector collapse. The stock's -7.46% three-day drop and subsequent 28% drawdown from ATH reflect the market's sober read: organic growth is low-to-mid single digits, not the prior 'double-digit' signal, and the path to recovery depends entirely on August–September rainfall and kharif volume pickup.
The company is a quality franchise — brand-led, disciplined on capital, long-term focused (R&D roadmap, digital, soil & plant health). But this quarter offered no evidence of demand momentum. Growth was engineered via pre-placement and mix-shift; margins held via product rotation, not operational leverage. For a holder, the key watch is monsoon and kharif completion by mid-August, Q2 organic growth (sans pre-placement), and whether management's revised 'industry 6–8%' guidance for FY27 is achievable or walks back further.
The number to track from here: organic revenue growth ex pre-placement. If that settles to low single digits and monsoon misses, the stock may re-test support below ₹200; if kharif comes good and Q2 shows stabilization, the drawdown could be a buying opportunity for longs. Verdict: Hold until August clarity.